Epidermal Langerhans cells (LC) 1 play a key role in the presentation of antigen to lymphocytes during the induction of delayed contact hypersensitivity (1-5). Normal functioning of the epidermal LC therefore may be a prerequisite for the induction and elicitation of contact allergic reactions. Recently, UVB light (10 mJ/cm ~ once daily for 4 consecutive d) has been reported to diminish the density of murine epidermal LC as determined by staining for membrane ATPase (6, 7) and to prevent the induction of contact sensitization to dinitrofluorobenzene (6). Furthermore, when such irradiation is administered in higher doses (720 mJ/cm 2 thrice weekly for 4 consecutive wk) even spleen cells from such UVB irradiated mice are unable to present antigens effectively (8). It was therefore of great interest to ascertain whether other physicochemical agents also have an effect on the number or functions of epidermal LC.
Lab Animals, Wayne, N. J.) were used in the studies on the effects of systemically administered glucocorticoids.
Topical and Systemic Glucocorticosteroid Administration. Guinea pigs were locally treated with 0.1% and 0.5% concentrations of betamethasone dipropionate (BD), betamethasone valerate (BV), cortisol (CL), and cortisone (CN). The drugs were prepared by dissolving the pure steroid compounds (Schering Corp., Kennilworth, N. J.) in absolute ethanol. Four 3 em 2 areas separated by 2 cm were mapped out on the dorsal surface of each guinea pig and marked with suture material. Twice daily, for either 14 or 21 d, one of these areas was treated with 0.05 ml of either one of the above steroid solutions, ethanol, or saline; the fourth area was left untreated. During the treatment period, two 6 mm punch biopsies were performed from each treatment and control area on days 0, 2, 4, 7, 10, and 14, and where applicable, on days 17 and 21. Biopsies were likewise obtained on days 2, 4, and 7 after treatment had been discontinued. Periodically, during and after treatment, biopsies were taken for EM. At the beginning of each experiment and at the time of each biopsy, the guinea pigs were shaved with an electric clipper. The remaining hair was then removed with Neet (Whitehall Laboratories Inc., New York).
Systemic glucocorticoid treatment was accomplished by intraperitoneal injections once daily for 5 consecutive d of 100 mg/kg, 10 mg/kg, or 1 mg/kg of either triamcinolone acetonide suspension (TAC) (E. R. Squibb & Sons, Inc., Princeton, N. J.) or methylprednisolone sodium succinate (MP) (The Upjohn Co., Kalamazoo, Mich.) in saline. Control animals received the same volume of normal saline (NS) instead of the drug. Biopsies were performed on the dorsal skin of all animals before the first injection and on days 0, 1, 2, 4, 9, 14, and 18 on the TACtreated animals. MP-treated animals were biopsied on days 0, 1, 2, 3, 4, 7, 9, and 11. Peripheral blood for blood counts was also obtained from the latter group by retro-orbital sinus puncture.
Light Microscopic Enumeration of LC.
Each biopsy was immersed in 1 M NaBr for 3-4 h at room temperature. The epidermal sheets were then easily separated from the underlying dermis. The epidermis was then fixed in 5% neutral formalin at 20°C for 20 min and stained for ATPase activity or for the presence of Ia antigen as described below. The stained specimens were allowed to air-dry (dermal side up) on cover slips and then mounted with Permount (Fisher Scientific Co., Pittsburgh, Pa.). The density of LC within each epidermal sheet was determined using a light microscope with a calibrated eyepiece (Zeiss Kpl W125 × 20, Carl Zeiss Inc., New York). The number of LC per mm 2 in one central and four peripheral areas of each epidermal sheet was determined; epidermal areas about the hair follicles were excluded. The reported LC density for each sheet represents the arithmetic average of the five counts ± 2 standard error per mm of skin surface.
A TPase and Ia Staining. Stains for ATPase activity were performed as described by Wolff and Winkelmann (10) . Staining for Ia-bearing epidermal cells was performed using an anti-Ia antiserum. This antiserum was prepared by immunizing inbred strain 2 guinea pigs with spleen cells from inbred strain 13 animals according to the method of Shevach, et al. (11) . Fixed epidermal samples were washed in 0.05 M Tris buffer in normal saline (pH 7.6) and incubated for 60 min at 37°C with anti-Ia antiserum. The tissue was then washed three times in the Tris buffer and incubated for 60 minutes at 37°C with 0.1 mg of protein A conjugated to horseradish peroxidase (Zymed Laboratories, Burlingame, Calif.) per ml of Tris buffer. The epidermal sheets were again washed three times with Tris buffer and stained with 0.1 ml of a solution containing 0.075 g of 3,3'-diaminobenzidine tetrachloride plus 0.1 ml of 3% H202/100 ml Tris buffer. The stained sheets were washed three more times with Tris buffer and allowed to air dry on cover slips.
Electron Microscopy. Biopsies taken for EM were fixed according to the method of Karnovsky (12) and post-fixed in OsO4. They were then embedded in Epon and cut in 700 .~ sections, stained with a uranyl acetate-lead citrate mixture, and studied under a Zeiss electron microscope 10 (Carl Zeiss Inc.).
White Blood Count. Counts were done using a standard hemocytometer dilution technique.
Differential counts were performed on blood smears stained with Wright's stain.
Statistics. All probabilities were determined using a two-or three-way analysis of variance. 1,000 developed somewhat slower and became significant only after day 7 (0.5%) or day 10 (0.1%). In each case, a near maximal decrease of 37-62% in the density of LC was noted with both staining procedures to occur by day 14 ( Figs. 1 and 2 ; Table I ). Treatment twice daily with either drug for an additional wk produced only a minimal further decline in LC density. It was noted, however, that in the animals treated for 21 d with 0.5% BD or BV, there was a significant decrease (P < 0.01) in LC in the control sites, suggesting that by this time sufficient systemic absorption of the drugs had occurred to affect untreated sites in these animals. Increased absorption of glucocorticoids via the biopsy-damaged skin areas could have added to this effect. Upon discontinuation of local treatment, the LC density in both treated and control sites returned to pretreatment levels within 7 d as measured by both criteria (Figs. I, 2 and 4). Double blind studies (Table II , guinea pigs 1 and 2) reaffirmed these findings for animals treated with a 0.1% BD solution. Application of 0.5% CL and 0.5% CN produced a slight decline (30 and 22%, respectively) in LC density (Tables I and III) as determined by ATPase stain; however, these decrements were barely significant (P < 0.05). No diminution of cells by Ia staining was noted with either drug (Tables I and III) . In double blind studies using 0.5% CL, the previously found decrement in LC density was not observed (Table II, guinea pigs 3 and 4) . Topical application of CL, 0.1%, and CN, 0.1%, solutions had no effect (data not shown).
Results

Topically Applied Glucocorticosteroids
EM STUDIES. Ultrastructural examination of the skin from animals treated topically with BD in either 0.5 or 0.1% concentrations showed alterations in the LC starting on day 4 that became maximal by day 7. These changes affected ~50% of the clearly recognizable LC in any given biopsy. Alterations noted included clumping of nuclear chromatin, dilatation of endoplasmic reticulum, swelling and condensation of mitochondria with flocculent densities, and myelin figures (Fig. 5) . No alterations were noted in the keratinocytes. By day 7 after cessation of topical steroids these changes could no longer be seen. The findings were similar to those seen in other forms of cell injury, such as those caused by ischemia (13) .
Systemically Administered Steroids. Guinea pigs were given five daily intraperitoneal injections of TAC at 10 mg/kg and 100 mg/kg (Fig. 6 ). 5 d after discontinuation of treatment, there was a 49% (100 mg/kg, P < 0.01) and a 28% (10 mg/kg, P < 0.05) decrease in LC density. The cell density returned to baseline values within 9 d after its nadir. When TAC was injected at 1 mg/kg, it did not produce any effect on the number of LC per mm 2 (Fig. 6) .
MP, 100 mg/kg, administered intraperitoneally, produced a significant decline in the LC density by the last day of treatment (P < 0.01, Fig. 7 ). Within 7 d after treatment was discontinued, the LC density had returned to control values. Neither MP at 10 mg/kg (Fig. 7) , 1 mg/kg, nor NS (data not shown) had any noticeable effect on LC density. None of the MP dosage used had any significant effect on (Fig. 7) or lymphocyte counts, which ranged from 55-70% of the total WBC count.
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Discussion
Both topical and systemic administration of potent glucocorticosteroids resulted in a decreased density of LC as assessed by staining for ATPase and Ia antigen. Furthermore, the decreases obtained in LC density correlated with the concentration and known vasoconstrictive potency of the drugs used. Topically, BD proved to be more rapid-acting and to result in a greater decrease in LC density than the other drugs; BV, CL, and CN followed in decreasing order. Systemically, at doses of 100 mg/kg, TAC and MP each caused an -40% decrease in LC density. The delayed action of TAC as compared with MP was to be expected in view of the relatively low water solubility of this drug.
The exact mechanism for the observed decrease in LC density is not clear, but at least three different possibilities should be considered. First, there may have been irreversible d a m a g e a n d a n a c t u a l decrease in n u m b e r t h r o u g h cellular d e a t h . A s e c o n d possibility is t h a t t h e cells were affected f u n c t i o n a l l y as a result o f a l t e r a t i o n s in m e m b r a n e surface a n t i g e n a n d e n z y m e expression. A l t h o u g h no direct e n u m e r a t i o n of L C was a t t e m p t e d b y E M , t h e t y p e of d a m a g e seen u l t r a s t r u c t u r a l l y d i d n o t exclude reversibility of the damage (13) . Changes in function without clear cytolytic effect have been described in guinea pig macrophages in the presence of glucocorticosteroids: both macrophage inhibition factor (14) and macrophage aggregation factor (15) are inhibited from acting on the macrophages. Furthermore, human monocytes have been found to express reduced rosette formation with erythrocytes coated with C3 or IgG, although phagocytosis of latex particles was unimpaired (16) . In view of the similarities previously summarized between LC and macrophages (I 7), a functional rather than killing effect of glucocorticosteroids on LC is a distinct possiblity. The recently reported studies of Lynch et al. (18) on the effects of topical glucocorticoids on the induction of contact sensitivity in mice suggest that the effect on LC is accompanied by functional impairment. Finally, it is possible that such a functional effect could also be the result of an enhanced migration of LC from the epidermis, similar to what has been observed during contact sensitivity reactions (19, 20) . The observation that the epidermis was repopulated with LC 7 d after the peak effect of local and systemic treatments does not help to clarify this issue; therefore, further studies are being conducted. It was somewhat puzzling that the rapid decrease in LC seen over the first 10 d of topically applied glucocorticoids was followed by a relative plateau on LC density during which no further major decrease was observed over the ensuing 10 d of treatment. Several possibilities, although not mutually exclusive, should be considered. A continuous influx of LC from the bone marrow (21) could establish an equilibrium with the damage inflicted by the steroids. It is also possible that two distinct LC: populations exist in relation to steroid sensitivity. One of these cell populations might include the indeterminate dendritic cells that are thought to represent immature LC containing few or no characteristic Birbeck granules (22, 23) . It has been shown that mouse macrophages express low and high affinity receptors for glucocorticoids, although there is no evidence that such receptors are expressed differently on different cell populations (24) . Finally, the possibility that the observed equilibrium is a result of the kinetics of drug accumulation in the skin cannot be excluded at this time.
As in man, lymphoid cells in guinea pigs are known to be relatively resistant to systemic steroid administration, although a decrease in circulating mononuclear cells can be obtained (25) (26) (27) . In our experiments, the glucocorticosteroid doses that produced a marked decrease in LC did not affect the peripheral WBC count, suggesting that in this system the LC is more sensitive to glucocorticosteroids than is the lymphocyte.
Early reports on the effect of glucocorticoids on the immune response have suggested that their major effect is on the presentation of antigen rather than on antibody production (28) . LC have been shown to serve as antigen-presenting cells in the induction of antigen-specific proliferation (1) (2) (3) (4) (5) . The effect of glucocorticosteroids on LC shown in this report is therefore in agreement with the conclusions of previous investigators. The observations that such disparate therapeutic modalities of treatment as ultraviolet light and glucocorticoids can prevent the induction of contact sensitivity, together with the fact that both agents have a negative effect on LC activity, strengthen the hypothesis that the LC is essential for the induction of contact sensitivity to environmental agents. Furthermore, these data suggest that the antiinflammatory action of glucorcorticosteroids in dermatologic disorders may, at least in part, be through the drug's ability to alter epidermal LC.
Summary
The effects of topical and systemic administration of various glucocorticoids on the density of epidermal Langerhans cells (LC) were studied in guinea pigs. Glucocorticolds, such as betamethasone dipropionate and valerate, caused a marked decrease in LC demonstrable by staining for cell membrane ATPase activity and Ia antigens. By electronmicroscopy, LC also showed morphologic alterations. The observed decrements in LC density correlated with the concentration and known vasoconstrictive potency of the glucocorticoids administered. The anti-inflammatory action of glucocorticoids in skin disorders may, at least in part, be through their ability to alter epidermal LC, thus interfering with the antigen-presenting functions of these cells.
